Sanochemia Pharmazeutika Competitors and Similar CompaniesClear all
APEIRON Biologics's competitors and similar companies include Polymun, ImmunoCellular Therapeutics and Celon Laboratories.
 APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. |  Polymun Polymun is a company specializing in contract development and manufacturing as well as creating liposomal formats of drugs for contract partners. |  ImmunoCellular Therapeutics ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers. |  Celon Laboratories Celon Laboratories engages in developing, manufacturing, and marketing pharmaceutical products in the areas of oncology, anti-infective, and critical care markets. | |
Founding Date | Founding Date 2005 | Founding Date 1992 | Founding Date 2006 | Founding Date 2007 |
Type | Type Private | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Wien, AT HQ | Locations Klosterneuburg, AT HQ | Locations Calabasas, US HQ | Locations Hyderabad, IN HQ |
Employees | Employees 5 | Employees 80 | Employees 357% decrease | Employees 561 |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 32.5m | Total funding raised $ 15.8m |
For sources of this data, please see the company profile
View Company Profiles
Polymun
HQ
Klosterneuburg, AT
Employees
80
Polymun is a company specializing in contract development and manufacturing as well as creating liposomal formats of drugs for contract partners.
View companyImmunoCellular Therapeutics
HQ
Calabasas, US
Employees
3
ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.
View companyCelon Laboratories
HQ
Hyderabad, IN
Employees
561
Celon Laboratories engages in developing, manufacturing, and marketing pharmaceutical products in the areas of oncology, anti-infective, and critical care markets.
View company